Denali Therapeutics Inc (DNLI) Price Prediction & ForecastDNLIDenali Therapeutics Inc

Alphio's DNLI stock price prediction model matches the current Denali Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $17.73 (+0.67%). The 1-week path is $17.60 (-0.08%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Denali Therapeutics Inc (DNLI) is currently not a strong buy due to its low RSI of 26.689, indicating oversold conditions, and a significant 5-day price drop of 9.46%. However, the stock has potential upside with analyst price targets suggesting a range of $30 to $36, which represents a potential upside of 70% to 104% from the current price of $17.61. The main risk is the ongoing negative net income, with a reported loss of $127.55 million in Q2 2026, which could impact future performance.

Denali Therapeutics Inc (DNLI) last closed at $17.61, losing -3.98%. These facts feed the 1-day and 1-week DNLI price prediction above.